Home Pharmacology Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
Pharmacology JoVE (Open Access) Citable · DOI

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development

DOI: 10.3791/56639-v
What you'll learn
  • Prepare and mount human myometrial tissue strips for contractility measurement
  • Analyze myometrial contraction patterns using force transduction
  • Evaluate pharmacological effects of novel compounds on uterine smooth muscle
Protocol

This article describes experimental protocols to study ex vivo contractions of human myometrium and their application in drug discovery. This technique is used to improve the understanding of myometrial physiology and pathophysiology as well as to validate pharmacological data from novel research probes or drug leads.

Difficulty
advanced
Total time
~4–6 hours per tissue sample (including equilibration and drug screening)
Model organism
Human myometrium (tissue explant)
Biosafety
BSL-1

Steps

1
Prepare and dissect myometrial tissue strips

Obtain human uterine tissue samples and carefully dissect longitudinal strips of myometrium for ex vivo contraction studies. Remove connective tissue and prepare uniform tissue specimens suitable for mounting.

▶ 00:49
2
Mount tissue strips in contraction measurement apparatus

Secure prepared myometrial strips between a fixed support and force transducer in a heated organ bath containing physiological buffer solution to enable real-time contractility recording.

▶ 03:00
3
Analyze myometrial contraction force and frequency

Record and quantify contractile parameters including peak force, contraction frequency, and duration using force transduction signals to establish baseline myometrial physiology.

▶ 04:06
4
Assess drug effects on contractility and receptor selectivity

Apply test compounds and novel pharmacological probes to myometrial preparations and measure changes in contraction amplitude, frequency, and pattern to evaluate drug efficacy and receptor specificity.

▶ 05:28
💬 Comments coming soon